WuXi Biologics, global contract research, development and manufacturing organization (CRDMO), will double capacity in its state-of-the-art drug substance facilities in Germany.    WuXi has facilities in the United States, China, Singapore, Ireland, and Germany. In 2020 WuXi invested in the construction and adaptation of two facilities in Germany. The Chempark Leverkusen sterile filling and freeze-drying plant will add a second variable filling line. WuXi’s Wuppertal state-of-the-art drug subst...